CZ's Nested Vials are designed to meet the
exterior dimensions of glass standard ISO 8362-1 and offer broad
compatibility with various aseptic fill-finish equipment available
in the market.
EXTON,
Pa., May 29, 2024 /PRNewswire/ -- West
Pharmaceutical Services, Inc. (NYSE: WST), a global leader in
innovative solutions for injectable drug administration, announced
today that it will unveil its new Daikyo Crystal Zenith® (CZ)
Nested Vials in Tub at the International Society for Cell and
Gene Therapy (ISCT) Annual Meeting taking place in Vancouver, Canada from May 29- June 1.
Designed to meet the exterior dimensions of glass standard
ISO-8362-1, CZ nested vials are a demonstrated containment solution
for cell and gene therapies, radiopharmaceuticals, and sensitive
molecules. CZ's attributes, such as maintaining container closure
integrity down to cryogenic temperatures, superior functional
recovery of viral vectors, low particulate specification (2% USP
<788>), break resistance, and low risk of chemical
interaction, make it ideal for advanced therapies. CZ vials have
demonstrated to be effective in safely storing gene therapy drugs
and meeting the packaging demands from preclinical to commercial
phases.
"West has been at the forefront of pharmaceutical packaging for
over 100 years and is the market leader for containment solutions
for cell and gene therapy treatments," said Cindy Reiss-Clark,
Chief Commercial Officer at West. "This new offering expands the CZ
platform to provide packaging configuration options for flexible
filling solutions of sensitive molecules."
Product Specifications
- CZ nested vials are available in 2mL and 10mL, and with ISO
8362-1 exterior dimensions.
- These vials offer flexible closure solutions with crimped
closures using NovaPure® stoppers or PLASCAP® press-fit closures
with Daikyo stoppers to meet manual, semi-automated or automated
capping requirements.
- The ready-to-use nested vials are first layered with a Tyvek®
slip sheet, heat sealed with a breathable Tyvek® lid, double bagged
and sterilized.
- The rigid structure and overall design of the vial nest tub
protects the vials during transit and promotes machinability.
About West
West Pharmaceutical Services, Inc. is a leading provider of
innovative, high-quality injectable solutions and services. As a
trusted partner to established and emerging drug developers, West
helps ensure the safe, effective containment and delivery of
life-saving and life-enhancing medicines for patients. With over
10,000 team members across 50 sites worldwide, West helps support
our customers by delivering approximately 43 billion components and
devices each year.
Headquartered in Exton,
Pennsylvania, West in its fiscal year 2023 generated
$2.95 billion in net sales. West is
traded on the New York Stock Exchange (NYSE: WST) and is included
on the Standard & Poor's 500 index. For more information, visit
www.westpharma.com.
West and the diamond logo and NovaPure are registered
trademarks of West Pharmaceutical Services, Inc.
Crystal Zenith and PLASCAP are registered trademarks of
Daikyo Seiko, Ltd.
Tyvek® is a registered trademark of DuPont de Nemours, Inc.
or its affiliate.
Crystal Zenith technology is licensed from Daikyo Seiko,
Ltd.
© 2024 West Pharmaceutical Services, Inc.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/west-introduces-daikyo-crystal-zenith-cz-ready-to-use-nested-vials-in-tub-at-the-international-society-for-cell-and-gene-therapy-302157350.html
SOURCE West Pharmaceutical Services, Inc.